Skip to content

A clinical study on Azhal keel vayu with Punnai vithai pattru (External therapy) and Ammaiyaar Koonthal Chooranam (Internal Medicine)

An open labelled double arm non randomized phase II clinical trial, to evaluate the therapeutic efficacy of punnai vithai pattru (External therapy) Ammaiyaar Koonthal Chooranam (Internal medicine) in the management of Azhal keel vayu (Osteoarthritis)

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/07/026639
Enrollment
40
Registered
2020-07-17
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M170- Bilateral primary osteoarthritis of knee

Interventions

Intervention1: PATTRU EXTERNAL THERAPY: PATTRU EXTERNAL THERAPY FOR 48 DAYS Control Intervention1: NIL: NIL

Sponsors

Government siddha medical college and hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: patients having symptoms of pain in single or both knee joints, swelling, tenderness, stiffness, crepitation and restricted movements Patients who are willing to give blood samples for laboratory investigation Patients who are willing to take x ray before and after treatment Willing for admission in IPD for 48 days or wiling to attend OPD regularly Patients who are willing to participate in this study with knowledge of potential risks and who are willing to sign the informed consent

Exclusion criteria

Exclusion criteria: Cardiac disease Rheumatoid and other types of arthritis Pregnant women and lactating mothers Trauma, fracture and ligament injury Patients with any other serious illness Benign and malignant neoplasm Immuno compromised patients Dermatological issues

Design outcomes

Primary

MeasureTime frame
Assessment of changes from baseline in universal pain assessment scale score at day 48 between Group I (Pattru External therapy) and Group II (Medicine and Pattru external therapy) Comparison of efficacy in patient Group I and Group IITimepoint: 48 Days

Secondary

MeasureTime frame
Assessment of quality of life by universal pain score scale Assessment of safety parametersTimepoint: 48 Days

Countries

India

Contacts

Public ContactDr M Ahamed Mohideen

Government Siddha Medical College and Hospital

dr.ahmed63@gmail.com9442542282

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026